← Back to Search

Behavioral Intervention

Counseling for Minority Stress (MST Trial)

N/A
Waitlist Available
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Must identify as non-heterosexual
Be older than 18 years old
Must not have
Current or history of psychosis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to study mental health differences in LGBTQ+ individuals and how minority stress, which is the internalized stigma from social marginalization, contributes to these differences. The goal is to reduce minority stress

Who is the study for?
This trial is for non-heterosexual LGBTQ+ individuals who are not currently dealing with a recent suicide attempt, eating disorder, narcotics use within the past 3 months, self-injury within the past 6 months, or any current or historical psychosis.
What is being tested?
The study tests Acceptance and Commitment Therapy (ACT) as a treatment to reduce minority stress among LGBTQ+ people. The goal is to see if ACT can lower mental health issues and improve overall wellbeing by addressing internalized stigma from social marginalization.
What are the potential side effects?
While ACT typically doesn't have physical side effects, participants may experience emotional discomfort when discussing sensitive topics related to their experiences of stigma and discrimination.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I identify as a member of the LGBTQ+ community.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a current or past diagnosis of psychosis.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 16 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Alcohol Problems
Anxiety
Depression
+3 more
Secondary study objectives
Affect
Experiential Avoidance
Problematic Pornography Use

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Treatment GroupExperimental Treatment1 Intervention
Participants receiving acceptance and commitment therapy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Acceptance and Commitment Therapy
2010
Completed Phase 1
~1490

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,656 Previous Clinical Trials
2,444,275 Total Patients Enrolled
~67 spots leftby May 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top